scholarly journals Endovascular Treatment of Abdominal Aortic Aneurysms in High-Surgical-Risk Patients Using Commercially Available Stent-Grafts

2010 ◽  
Vol 17 (1) ◽  
pp. 89-94 ◽  
Author(s):  
Célio Teixeira Mendonça ◽  
Cláudio Augusto de Carvalho ◽  
Janaína Weingärtner ◽  
Alexandre Yoshiharu Shiomi ◽  
Daniel Simões de Melo Costa
2013 ◽  
Vol 57 (5) ◽  
pp. 19S
Author(s):  
Celio T. Mendonca ◽  
Claudio A. Carvalho ◽  
Janaina Weingartner ◽  
Alexandre Y. Shiomi ◽  
Daniel S. Costa ◽  
...  

2017 ◽  
Vol 38 ◽  
pp. e25
Author(s):  
Raphaël Coscas ◽  
Henri Lamas ◽  
Isabelle Javerliat ◽  
Amélie Mlynski ◽  
Olivier Goëau-Brissonnière ◽  
...  

Author(s):  
Ernesto Arenas Azofra ◽  
Cristóbal Iglesias Iglesias ◽  
Carmen González Canga ◽  
Francisco Álvarez Marcos ◽  
Carlota Fernández Prendes ◽  
...  

2018 ◽  
Vol 67 (1) ◽  
pp. 113-118 ◽  
Author(s):  
Pablo Marques De Marino ◽  
Isaac Martinez Lopez ◽  
Ferran Pla Sanchez ◽  
Iñaki Cernuda Artero ◽  
Maday Cabrero Fernandez ◽  
...  

2009 ◽  
Vol 8 (1) ◽  
pp. 56-64 ◽  
Author(s):  
Célio Teixeira Mendonça ◽  
Ricardo Cesar Rocha Moreira ◽  
Cláudio Augusto de Carvalho ◽  
Bárbara D´Agnoluzzo Moreira ◽  
Janaína Weingärtner ◽  
...  

Background: Following the publication of a prospective randomized trial (Endovascular Aneurysm Repair Trial 2 - EVAR2) that questioned the benefits of endovascular repair of abdominal aortic aneurysms (AAA) in high-surgical-risk patients, we decided to analyze our initial and long-term results with endovascular AAA repair in this patient population. Objective: To evaluate the operative mortality, long-term survival, frequency of secondary operations, outcome of the aneurysm sac, primary and secondary patency rates, and rupture rate after aortic stent-graft placement in high-surgical-risk patients. Methods: From April 2002 to February 2008, 40 high-surgical and anesthetic risk patients with an AAA managed by a bifurcated aortic endograft were entered in a prospective registry. Data concerning diagnosis, operative risk, treatment and follow-up were analyzed in all patients Results: Twenty-four Excluder® and 16 Zenith® stent-grafts were successfully implanted. Thirty patients (75%) were classed ASA III and 10 (25%) were ASA IV. Mean aneurysm diameter was 64 mm. Operative mortality was 2.5%. Two patients required reintervention during the mean follow-up of 28.5 months. Survival rate at 3 years was 95%. There were four endoleaks, one case of endotension, and one endograft limb occlusion. Primary and secondary patency rates at 3 years were 97.5 and 100%, respectively. There were no ruptures. Conclusions: Initial and long-term results with endovascular treatment of AAA in high-surgical-risk patients were satisfactory, and appear to justify such approach for this patient population.


Sign in / Sign up

Export Citation Format

Share Document